Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo

Identifieur interne : 002149 ( Main/Exploration ); précédent : 002148; suivant : 002150

EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo

Auteurs : Linda L. Theisen [Luxembourg (pays)] ; Claude P. Muller [Luxembourg (pays)]

Source :

RBID : Pascal:12-0378938

Descripteurs français

English descriptors

Abstract

A prodelphinidin-rich extract from Pelargonium sidoides DC, EPs® 7630 (Umckaloabo®), which is licensed to treat respiratory tract infections such as acute bronchitis, was investigated for its antiviral effects. EPs® 7630 showed dose-dependent anti-influenza activity at non-toxic concentrations against pandemic H1N1, oseltamivir-sensitive and -resistant seasonal H1N1, seasonal H3N2 and the laboratory H1N1 strain A/Puerto Rico/8/34, while it had no antiviral activity against adenovirus or measles virus. The extract inhibited an early step of influenza infection and impaired viral hemagglutination as well as neuraminidase activity. However, EPs® 7630 did not exhibit a direct virucidal effect, as virus preincubation (unlike cell preincubation) with the extract did not influence infectivity. Importantly, EPs® 7630 showed no propensity to resistance development in vitro. Analysis of EPs® 7630 constituents revealed that prodelphinidins represent the active principle. Chain length influenced antiviral activity, as monomers and dimers were less effective than oligo- and polymers. Importantly, gallocatechin and its stereoisomer epigallocatechin exert antiviral activity also in their monomeric form. In addition, EPs® 7630 administered by inhalation significantly improved survival, body weight and body temperature of influenza-infected mice, without obvious toxicity, demonstrating the benefit of EPs® 7630 in treatment of influenza.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo</title>
<author>
<name sortKey="Theisen, Linda L" sort="Theisen, Linda L" uniqKey="Theisen L" first="Linda L." last="Theisen">Linda L. Theisen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Institute of Immunology, Centre de Recherche Public de la SantélLaboratoire National de Santé, 20A rue Auguste Lumière</s1>
<s2>1950 Luxembourg</s2>
<s3>LUX</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Luxembourg (pays)</country>
<wicri:noRegion>1950 Luxembourg</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muller, Claude P" sort="Muller, Claude P" uniqKey="Muller C" first="Claude P." last="Muller">Claude P. Muller</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Institute of Immunology, Centre de Recherche Public de la SantélLaboratoire National de Santé, 20A rue Auguste Lumière</s1>
<s2>1950 Luxembourg</s2>
<s3>LUX</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Luxembourg (pays)</country>
<wicri:noRegion>1950 Luxembourg</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">12-0378938</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0378938 INIST</idno>
<idno type="RBID">Pascal:12-0378938</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000515</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001923</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000673</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000673</idno>
<idno type="wicri:doubleKey">0166-3542:2012:Theisen L:eps:umckaloabo:an</idno>
<idno type="wicri:Area/Main/Merge">002209</idno>
<idno type="wicri:Area/Main/Curation">002149</idno>
<idno type="wicri:Area/Main/Exploration">002149</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo</title>
<author>
<name sortKey="Theisen, Linda L" sort="Theisen, Linda L" uniqKey="Theisen L" first="Linda L." last="Theisen">Linda L. Theisen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Institute of Immunology, Centre de Recherche Public de la SantélLaboratoire National de Santé, 20A rue Auguste Lumière</s1>
<s2>1950 Luxembourg</s2>
<s3>LUX</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Luxembourg (pays)</country>
<wicri:noRegion>1950 Luxembourg</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muller, Claude P" sort="Muller, Claude P" uniqKey="Muller C" first="Claude P." last="Muller">Claude P. Muller</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Institute of Immunology, Centre de Recherche Public de la SantélLaboratoire National de Santé, 20A rue Auguste Lumière</s1>
<s2>1950 Luxembourg</s2>
<s3>LUX</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Luxembourg (pays)</country>
<wicri:noRegion>1950 Luxembourg</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Antiviral research</title>
<title level="j" type="abbreviated">Antivir. res.</title>
<idno type="ISSN">0166-3542</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Antiviral research</title>
<title level="j" type="abbreviated">Antivir. res.</title>
<idno type="ISSN">0166-3542</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiviral</term>
<term>Biological activity</term>
<term>Extract</term>
<term>Flavonoid</term>
<term>In vitro</term>
<term>In vivo</term>
<term>Influenza A virus</term>
<term>Influenzavirus</term>
<term>Pelargonium</term>
<term>Polyphenol</term>
<term>Root</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Extrait</term>
<term>Pelargonium</term>
<term>Racine</term>
<term>Influenzavirus</term>
<term>In vitro</term>
<term>Activité biologique</term>
<term>In vivo</term>
<term>Virus grippal A</term>
<term>Polyphénol</term>
<term>Flavonoïde</term>
<term>Antiviral</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A prodelphinidin-rich extract from Pelargonium sidoides DC, EPs® 7630 (Umckaloabo®), which is licensed to treat respiratory tract infections such as acute bronchitis, was investigated for its antiviral effects. EPs® 7630 showed dose-dependent anti-influenza activity at non-toxic concentrations against pandemic H1N1, oseltamivir-sensitive and -resistant seasonal H1N1, seasonal H3N2 and the laboratory H1N1 strain A/Puerto Rico/8/34, while it had no antiviral activity against adenovirus or measles virus. The extract inhibited an early step of influenza infection and impaired viral hemagglutination as well as neuraminidase activity. However, EPs® 7630 did not exhibit a direct virucidal effect, as virus preincubation (unlike cell preincubation) with the extract did not influence infectivity. Importantly, EPs® 7630 showed no propensity to resistance development in vitro. Analysis of EPs® 7630 constituents revealed that prodelphinidins represent the active principle. Chain length influenced antiviral activity, as monomers and dimers were less effective than oligo- and polymers. Importantly, gallocatechin and its stereoisomer epigallocatechin exert antiviral activity also in their monomeric form. In addition, EPs® 7630 administered by inhalation significantly improved survival, body weight and body temperature of influenza-infected mice, without obvious toxicity, demonstrating the benefit of EPs® 7630 in treatment of influenza.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Luxembourg (pays)</li>
</country>
</list>
<tree>
<country name="Luxembourg (pays)">
<noRegion>
<name sortKey="Theisen, Linda L" sort="Theisen, Linda L" uniqKey="Theisen L" first="Linda L." last="Theisen">Linda L. Theisen</name>
</noRegion>
<name sortKey="Muller, Claude P" sort="Muller, Claude P" uniqKey="Muller C" first="Claude P." last="Muller">Claude P. Muller</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002149 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002149 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:12-0378938
   |texte=   EPs® 7630 (Umckaloabo®), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021